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Research – Our impact on society
Improving the life of people with co-existing mental 
health disorders and substance misuse problems  
There is a strong connection 
between mental health and 
substance use. Substances can 
trigger or exacerbate pre-existing 
psychiatric problems and psychiatric 
symptoms can develop as a result 
of withdrawals, as acute effects 
while intoxicated by drugs or 
alcohol (for example, cannabis or 
amphetamine induced psychosis), 
or can follow long-term use or 
dependence. Substance Use and 
Misuse Studies (SUMS) courses at 
UWL have contributed to enhancing 
knowledge and competence in 
practitioners working with clients 
with co-morbid mental health and 
substance use problems.
A report commissioned by the Department 
of Health found that 75% of users of drug 
services and 85% of users of alcohol services 
were experiencing mental health problems. 
It is also estimated that a third of patients 
in mental health services have a substance 
misuse problem. Substance misuse is under-
diagnosed in psychiatric patients and a  
large number of individuals in addiction 
services who suffer from moderate mental 
illness are not diagnosed with a psychiatric 
disorder. A recent study conducted by Denis 
Mirlesse, whilst he was a UWL student 
on the Graduate Diploma in Psychology, 
assessed 100 participants who were in 
treatment for substance misuse and found 
that they suffered from significantly higher 
levels of depression, anxiety, stress and 
overall negative affect than the non-clinical 
population; however the psychological 
distress was often not identified nor 
addressed. Patients with 'dual diagnosis' 
are one of the most vulnerable groups 
in society, with high risk of poor physical 
health, high risk of suicide, high levels 
of personality disorder, great levels of 
disability and a low quality of life. Moreover, 
because mental illness and substance 
misuse are conditions that have historically 
been associated with a sense of blame, 
shame or secrecy, individuals with co-
morbidity are often affected by double 
stigmatisation, which may prevent them 
from seeking help and from having a 
fulfilling professional and social life. 
Often practitioners are faced with the 
'chicken and egg' dilemma: what comes 
first? Are the psychiatric symptoms a 
result of drug use, or is substance use a 
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self-medication strategy to cope with a 
primary mental disorder? Most of the time 
the answer is not straightforward: the 
relationship between the two disorders is 
complex, especially in long-term conditions. 
While, in some cases the answer may not be 
clinically important; what is certain is that 
substance misuse affects mental health 
recovery and vice versa. It is becoming 
apparent that common risk factors, such as 
trauma, domestic violence or pre-existing 
predisposition, can underpin both mental 
disorders and substance misuse and, while 
practitioners are trying to unravel the knot, 
clients may fall between the gaps. 
The best treatment that can be offered 
is where mental health and substance 
misuse services work together in a 
coordinated manner, although currently 
this model is far from being implemented 
effectively. In 2007 the Drug Misuse and 
Dependence: UK Guidelines on Clinical 
Management expressed concern about lack 
of specified core competencies, inadequate 
assessment and poor integrated care. 
Despite progress having been made, the 
newly published Five Year Forward View 
for Mental Health recognises the need to 
develop the workforce so it can respond 
more effectively to substance misuse. 
Judgmental attitudes of healthcare 
professionals towards clients with 
substance misuse problems have also  
been identified as creating a barrier to 
effective treatment.
Dr Raffaella Margherita Milani in the 
School of Human and Social Sciences 
was recently offered the opportunity to 
be involved in an exciting and promising 
approach that will be rolled out for the 
first time in the UK in West London. The 
programme is called Dual Diagnosis 
Anonymous (DDA) and is based on the 
AA 12-step model, with the addition of 
five steps geared towards supporting the 
specific needs of dual diagnosis clients.
Funding was secured for a 12-month pilot, 
which started in summer 2016. Dr Milani 
had the opportunity to participate in a 
group that has recently adopted the DDA 
model and was impressed by the way 
participants felt free to share their feelings 
and emotions regarding their everyday 
struggles, and their successes in dealing 
with their mental illness and substance use. 
The group offered a space where attendees 
were listened to in a non-judgemental, 
empathetic and respectful manner. A 
reccurring topic was the crucial role that 
the group had for them in achieving and 
sustaining recovery. One young participant 
who attended the DDA group for the first 
time left with a smile saying "this is the first 
time that I have connected with a group". 
Dr Milani experienced first-hand the power 
of peer support when she facilitated 
groups of families with alcohol and drug 
related problems. Self-help groups cannot 
and should not substitute the work of 
professionals, but they certainly offer an 
on-going, invaluable and cost-effective 
resource that can improve the life of 
individuals and people around them. It is 
the hope that the evaluation of the DDA 
pilot will help the programme spread in 
London and other parts of the UK.
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